Postmenopausal hormone therapy for prevention of fractures: How good is the evidence?

JAMA

Volumn 285, Issue 22, 2001, Pages 2909-2910

  Grady, D ^a   Cummings, S R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN;

BONE ATROPHY; CLINICAL TRIAL; DRUG EFFICACY; EDITORIAL; EVIDENCE BASED MEDICINE; FEMALE; FRACTURE; HORMONE SUBSTITUTION; HUMAN; OSTEOPOROSIS; POSTMENOPAUSE; PRIORITY JOURNAL; QUALITY OF LIFE; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 0035854023     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.285.22.2909     Document Type: Editorial

References (18)

1. Estrogen replacement therapy and fractures in older women: Study of Osteoporotic Fractures Research Group
2. Hormone therapy to prevent disease and prolong life in postmenopausal women
3. Prior to use of estrogen replacement therapy, are users healthier than nonusers?
4. Effects of hormone therapy on bone mineral density: Results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial
5. The comparative effect on bone density, endometrium, and lipids of continuous hormones as replacement therapy (CHART Study): A randomized controlled trial
6. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older
7. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: Results from the fracture intervention trial
8. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures: Fracture Intervention Trial Research Group
9. Effect of risedronate on the risk of hip fracture in elderly women: HIP Intervention Program Study Group
10. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: Results from a 3-year randomized clinical trial
11. A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: The prevent recurrence of osteoporotic fractures study
12. Hormone replacement theapy and prevention of nonvertebral fractures: A meta-analysis of randomized trials
13. Effects of hormone replacement therapy on clinical fractures and height loss: The Heart and Estrogen/progestin Replacement Study (HERS)
14. Hormonal replacement therapy reduces forearm fracture incidence in recent postmenopausal women: Results of the Danish Osteoporosis Prevention Study
15. Postmenopausal hormone therapy increases risk for venous thromboembolic disease: The Heart and Estrogen/progestin Replacement Study
16. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
17. Breast cancer hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52705 women with breast cancer 108411 women without breast cancer
18. Lifetime fracture risk: An approach to hip fracture risk assessment based on bone mineral density and age